Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells
- PMID: 28416488
- DOI: 10.1158/0008-5472.CAN-16-2171
Activation of NOTCH Signaling by Tenascin-C Promotes Growth of Human Brain Tumor-Initiating Cells
Abstract
Oncogenic signaling by NOTCH is elevated in brain tumor-initiating cells (BTIC) in malignant glioma, but the mechanism of its activation is unknown. Here we provide evidence that tenascin-C (TNC), an extracellular matrix protein prominent in malignant glioma, increases NOTCH activity in BTIC to promote their growth. We demonstrate the proximal localization of TNC and BTIC in human glioblastoma specimens and in orthotopic murine xenografts of human BTIC implanted intracranially. In tissue culture, TNC was superior amongst several extracellular matrix proteins in enhancing the sphere-forming capacity of glioma patient-derived BTIC. Exogenously applied or autocrine TNC increased BTIC growth through an α2β1 integrin-mediated mechanism that elevated NOTCH ligand Jagged1 (JAG1). Microarray analyses and confirmatory PCR and Western analyses in BTIC determined that NOTCH signaling components including JAG1, ADAMTS15, and NICD1/2 were elevated in BITC after TNC exposure. Inhibition of γ-secretase and metalloproteinase proteolysis in the NOTCH pathway, or silencing of α2β1 integrin or JAG1, reduced the proliferative effect of TNC on BTIC. Collectively, our findings identified TNC as a pivotal initiator of elevated NOTCH signaling in BTIC and define the establishment of a TN-α2β1-JAG1-NOTCH signaling axis as a candidate therapeutic target in glioma patients. Cancer Res; 77(12); 3231-43. ©2017 AACR.
©2017 American Association for Cancer Research.
Similar articles
-
ADAM-9 is a novel mediator of tenascin-C-stimulated invasiveness of brain tumor-initiating cells.Neuro Oncol. 2015 Aug;17(8):1095-105. doi: 10.1093/neuonc/nou362. Epub 2015 Feb 1. Neuro Oncol. 2015. PMID: 25646025 Free PMC article.
-
MIF Maintains the Tumorigenic Capacity of Brain Tumor-Initiating Cells by Directly Inhibiting p53.Cancer Res. 2016 May 1;76(9):2813-23. doi: 10.1158/0008-5472.CAN-15-1011. Epub 2016 Mar 15. Cancer Res. 2016. PMID: 26980763
-
Tumor microenvironment tenascin-C promotes glioblastoma invasion and negatively regulates tumor proliferation.Neuro Oncol. 2016 Apr;18(4):507-17. doi: 10.1093/neuonc/nov171. Epub 2015 Aug 27. Neuro Oncol. 2016. PMID: 26320116 Free PMC article.
-
Tenascin-C Function in Glioma: Immunomodulation and Beyond.Adv Exp Med Biol. 2020;1272:149-172. doi: 10.1007/978-3-030-48457-6_9. Adv Exp Med Biol. 2020. PMID: 32845507 Review.
-
Brain tumor stem cells as therapeutic targets in models of glioma.Yonsei Med J. 2010 Sep;51(5):633-40. doi: 10.3349/ymj.2010.51.5.633. Yonsei Med J. 2010. PMID: 20635435 Free PMC article. Review.
Cited by
-
Identification of core differentially methylated genes in glioma.Oncol Lett. 2019 Dec;18(6):6033-6045. doi: 10.3892/ol.2019.10955. Epub 2019 Oct 2. Oncol Lett. 2019. PMID: 31788078 Free PMC article.
-
Extracellular Matrix Protein Tenascin C Increases Phagocytosis Mediated by CD47 Loss of Function in Glioblastoma.Cancer Res. 2019 May 15;79(10):2697-2708. doi: 10.1158/0008-5472.CAN-18-3125. Epub 2019 Mar 21. Cancer Res. 2019. PMID: 30898840 Free PMC article.
-
Oncogenic and Tumor-Suppressive Functions of NOTCH Signaling in Glioma.Cells. 2020 Oct 15;9(10):2304. doi: 10.3390/cells9102304. Cells. 2020. PMID: 33076453 Free PMC article. Review.
-
Tenascin C promotes cancer cell plasticity in mesenchymal glioblastoma.Oncogene. 2020 Nov;39(46):6990-7004. doi: 10.1038/s41388-020-01506-6. Epub 2020 Oct 19. Oncogene. 2020. PMID: 33077835
-
Toward understanding cancer stem cell heterogeneity in the tumor microenvironment.Proc Natl Acad Sci U S A. 2019 Jan 2;116(1):148-157. doi: 10.1073/pnas.1815345116. Epub 2018 Dec 26. Proc Natl Acad Sci U S A. 2019. PMID: 30587589 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Miscellaneous